MedCath Corp (NASDAQ:MDTH)

CAPS Rating: 2 out of 5

A healthcare provider focused primarily on the diagnosis and treatment of cardiovascular disease.

Results 1 - 6 of 6

Recs

0
Member Avatar zientsa (31.58) Submitted: 10/13/2010 12:42:44 PM : Outperform Start Price: $5.33 MDTH Score: -20.84

Liquidating, properties should be worth fifty percent more then the current price. High quality specialty hospitals.

Recs

0
Member Avatar LawfordCap (99.84) Submitted: 2/20/2010 12:12:18 PM : Outperform Start Price: $3.56 MDTH Score: +41.32

interesting stock:
low ps
but no return on equity data available

Recs

1
Member Avatar SanDieguito (< 20) Submitted: 11/14/2007 10:37:34 AM : Underperform Start Price: $11.53 MDTH Score: +71.51

down $4 to $22

Recs

2
Member Avatar kpedo2000 (22.47) Submitted: 9/4/2007 12:44:38 PM : Outperform Start Price: $15.13 MDTH Score: -87.94

MedCath continues to expand its base of cardiac specialty hospitals. Trades at a discount to peers on EV/Ebitda basis. New management has solidified operations and added cost controls. Long term cardiac care is in the sweet spot of serving an aging Baby Boomer generation.

Recs

0
Member Avatar freudtheelder (< 20) Submitted: 1/29/2007 11:23:00 PM : Outperform Start Price: $14.84 MDTH Score: -94.55

kkr

Recs

0
Member Avatar MikeSu007 (92.83) Submitted: 12/13/2006 2:39:09 PM : Outperform Start Price: $13.96 MDTH Score: -91.30

A David Nierenberg pick... many other good institutions are buying it up.

Results 1 - 6 of 6

Featured Broker Partners


Advertisement